Manoranjenni Chetty
Manoranjenni Chetty publishes mostly in Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology, on topics such as Pharmacogenetics and Drug Metabolism, Pharmacological Effects and Toxicity Studies and Epilepsy research and treatment.
- World rank
- #1,950,767 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #143,934 of 367,258
- Works
- 56
- Citations
- 1.4k
- Citations per work
- 24.4
What does Manoranjenni Chetty research?
Manoranjenni Chetty's work is mostly in Medicine (34%), Pharmacology, Toxicology and Pharmaceutics (11%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2646.1%
- Health Sciences1934.3%
- Medicine1934.3%
- Life Sciences1119.6%
- 1Psychiatry and Mental health16% of their works
- 2Pediatrics, Perinatology and Child Health13% of their works
- 3Pharmacology11% of their works
- 4Oncology5% of their works
- 5Molecular Biology4% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
- Pharmacogenetics and Drug Metabolism
- Pharmacological Effects and Toxicity Studies
- Epilepsy research and treatment
- Schizophrenia research and treatment
- Drug Transport and Resistance Mechanisms
- Pharmaceutical studies and practices
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
Which keywords describe Manoranjenni Chetty's research?
The keywords of their largest research topics: Antiepileptic Drugs, Cytochrome P450, Pharmacogenetics, Prenatal Exposure, Teratogenicity, Epilepsy, Seizures and Antipsychotic Drugs.
- Biopharmaceuticals
- Antibody Engineering
- Off-Label Drug Use
- Multidrug Resistance
- ATP-dependent Transporters
- Antipsychotic Drugs
- Epilepsy
- Prenatal Exposure
- Cytochrome P450
- Antiepileptic Drugs
- Pharmacogenetics
- Teratogenicity
- Seizures
- Neurocognitive Deficits
- Monoclonal Antibodies
- Therapeutic Antibodies
- Pediatric Pharmacokinetics
- Fc Receptors
- Protein Aggregation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Antiepileptic Drugs272 topics
- Cytochrome P450171 topic
- Pharmacogenetics171 topic
- Prenatal Exposure151 topic
- Teratogenicity151 topic
- Epilepsy121 topic
- Seizures121 topic
- Antipsychotic Drugs111 topic
- Neurocognitive Deficits111 topic
- ATP-dependent Transporters71 topic
- Monoclonal Antibodies72 topics
- Multidrug Resistance71 topic
- Therapeutic Antibodies72 topics
- Off-Label Drug Use51 topic
- Pediatric Pharmacokinetics51 topic
- Antibody Engineering41 topic
- Fc Receptors41 topic
- Biopharmaceuticals31 topic
- Protein Aggregation31 topic
Where does Manoranjenni Chetty work?
Manoranjenni Chetty's main affiliation in the publication record is Simcyp (United Kingdom), United Kingdom.
How many publications and citations does Manoranjenni Chetty have?
OpenAlex counts 56 works and 1,364 citations for Manoranjenni Chetty, an h-index of 22, ranking #1,950,767 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Manoranjenni Chetty. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.